RBC Capital Upgrades Alnylam Pharmaceuticals (ALNY) to Outperform
Tweet Send to a Friend
RBC Capital analyst Luca Issi upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE